Wellington Management Group’s ProQR Therapeutics PRQR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-3,084,150
Closed -$2.79M 2167
2022
Q1
$2.79M Sell
3,084,150
-933,610
-23% -$3.13M ﹤0.01% 1528
2021
Q4
$32.2M Sell
4,017,760
-1,334,085
-25% -$10.2M 0.01% 964
2021
Q3
$44.8M Buy
5,351,845
+1,648,814
+45% +$10.8M 0.01% 846
2021
Q2
$25M Buy
3,703,031
+308,785
+9% +$1.99M ﹤0.01% 1039
2021
Q1
$22.4M Sell
3,394,246
-61,519
-2% -$314K ﹤0.01% 1039
2020
Q4
$14.5M Sell
3,455,765
-1,266,475
-27% -$5.34M ﹤0.01% 1096
2020
Q3
$22.6M Sell
4,722,240
-146,175
-3% -$764K ﹤0.01% 925
2020
Q2
$29.6M Sell
4,868,415
-183,876
-4% -$993K 0.01% 829
2020
Q1
$27.7M Sell
5,052,291
-442,837
-8% -$3.4M 0.01% 792
2019
Q4
$54.5M Buy
5,495,128
+4,790,532
+680% +$37.3M 0.01% 733
2019
Q3
$4.06M Buy
704,596
+426,073
+153% +$3.4M ﹤0.01% 1401
2019
Q2
$2.54M Buy
+278,523
New +$3.29M ﹤0.01% 1560

Other funds holding PRQR

Wellington Management Group's PRQR Position: Q2 2022 in Review

Wellington Management Group sold out of ProQR Therapeutics (PRQR) in Q2 2022, closing a stake of 3,084,150 shares — an estimated $2.79M sold.

Wellington Management Group first reported a position in PRQR in Q2 2019 and held it in 12 quarters. The position peaked at $54.5M in Q4 2019. 51 funds tracked by Wall St. Rank hold PRQR as of Q2 2022.

  • Wellington Management Group reported no remaining ProQR Therapeutics position as of Q2 2022 after selling out during the quarter.
  • Wellington Management Group sold 3,084,150 ProQR Therapeutics shares in Q2 2022, an estimated $2.79M.
  • Wellington Management Group first reported a position in ProQR Therapeutics in Q2 2019 and held it in 12 quarters.
  • Wellington Management Group's ProQR Therapeutics position peaked at $54.5M in Q4 2019.
  • 51 funds tracked by Wall St. Rank held ProQR Therapeutics as of Q2 2022.

Based on Wellington Management Group's 13F filing for Q2 2022, filed 15 Aug 2022.